Mortality and cost of therapy of carbapenem susceptible vs resistant Gram-negative infections among hospitalised patients in India: a multicentric surveillance (2022-2025).

Zavicefta (ceftazidime/avibactam) - Pfizer, AbbVie

http://www.ncbi.nlm.nih.gov/pubmed/42707186

; Bhawna Yadav; Camilla Rodrigues; Kamini Walia; Nitin Bansal; Prabhat Kumar; Sonam Vijay; V C Ohri; V Ramasubramanian

Sep 9, 2026